$3.06
$0.00 (0.00%)
End-of-day quote: 05/03/2024
NasdaqCM:MEIP
MEI Pharma Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2008 | 2007 | 2006 | 2005 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$48.82M | $40.70M | $34.80M | $4.92M | $1.62M | $23.25M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | |
| GM % | Gross Margin % |
|
100.00% | 100.00% | 95.95% | 13.27% | -108.57% | 78.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| OM | Operating Margin |
|
-75.31% | -185.48% | -173.65% | 0.00% | 0.00% | 10.25% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-5.02 | $-12.08 | $-12.21 | $-12.50 | $-14.66 | $1.40 | $-12.20 | $-23.20 | $-27.00 | $-22.00 | $-67.20 | $-216.00 | $-26400.01 | $-156.00 | $-132.00 | $-19200.01 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.00% | -0.00% | 0 | 0 | |
| Sha. | Shares |
|
6.66m | 133.15m | 112.62m | 73.55m | 70.41m | 36.77m | 34.16m | 34.16m | 21.61m | 17.12m | 3.42m | 1.15m | 1.06m | 0.95m | 0.95m | 0.95m | |
| OCF | Operating Cash Flow |
|
$-52.48M | $-48.75M | $-31.96M | $-29.42M | $-21.04M | $3.49M | $-17.86M | $-28.07M | $-19.45M | $-10.04M | $-7.08M | $-11.50M | $-10.79M | $-9.09M | $-5.58M | $-7.97M | |
| FCF | Free Cash Flow |
|
$-52.52M | $-49.23M | $-32.67M | $-29.64M | $0.00M | $-6.59M | $0.00M | $-28.09M | $-19.50M | $-10.08M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | |
| FCFS | Free Cash Flow Per Share |
|
$-7.88 | $-0.40 | $-0.29 | $-0.42 | $-0.51 | $0.09 | $-0.52 | $-1.00 | $-0.97 | $-0.99 | $-3.15 | $-10.10 | $-10.24 | $-9.58 | $-5.88 | $-8.70 |
